Convex have advised the Shareholders of Thoroughbred Remedies Manufacturing Limited (TRM), the market leading Irish company specialised in the development of high-quality nutritional supplements for horses, on their sale to the Equine Care Group, Europe’s leading group of specialist equine hospitals and clinics.
TRM is European market leader in the development and distribution of high-quality feed supplements and general healthcare products in horses.
The company was founded in 1989 in Newbridge, the “Horse Capital” of Ireland. TRM’s facilities have grown into a state-of-the-art 7300 m2 production facility that uses the latest technology to ensure that all products are manufactured to exacting international standards.
TRM operates in more than 70 countries worldwide and has developed more than 55 healthcare products. Thanks to their long-standing meticulous attention to detail, focus on quality, R&D and innovation, TRM enjoys a world-renowned reputation for excellence.
TRM is accredited with the highest international standard for animal feed production, namely GMP+ (Good Manufacturing Process). Only top-quality ingredients are used, and the entire production process is closely monitored through an HACCP system.
The mission of TRM is to fulfil the specific nutritional needs for horses worldwide and also to provide maximum support for sport horses during their efforts. TRM products are therefore used in more than 70 countries by winners in all disciplines.
